We at Bio Usawa share a passion for health justice and access to lifesaving, affordable biotherapeutics for patients in Africa and beyond. And our passion clearly resonates with key audiences across the healthcare spectrum, including faculty and students at Stanford University Medical School’s Center for Innovation in Global Health (see photo) where today I had the privilege to deliver a presentation on the rapid progress the company has made just in a few short months. Our fast-paced and can-do culture demands that we bring on key personnel to continue on our path.
Learn more about our company and hiring needs here:
https://www.biousawa.com/careers
Bio Usawa has a singular mission: to manufacture and commercialize high-quality, effective and affordable biosimilars for patients in Africa. We are applying our 100+ years of combined experience in the industry in partnership with governments, agencies, educators and health professionals to make transformative biomedicines in Africa, by Africans, for Africans and beyond.
Click here to learn more about our company's recent successes and download our new White Paper on Regulatory Approaches to Biosimilars in Africa.
In honor of World Cancer Research Day, the African Organization for Research and Training in Cancer (AORTIC) is proud to announce the launch of its inau…
September 2025Bio Usawa, a company focused on producing life-saving, affordable monoclonal therapies for Africa and beyond, has signed an agreement with the Desai Law…
September 2025The Bio Usawa Biotechnology (BUI) delegation, led by Dr. Menghis Bairu, CEO, had the honor of meeting with Botswana’s Vice President and Minister of Fin…
August 2025